• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

eMERGE 网络中基因组结果回报的参与者选择。

Participant choices for return of genomic results in the eMERGE Network.

机构信息

Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.

Columbia University Irving Medical Center, New York, NY, USA.

出版信息

Genet Med. 2020 Nov;22(11):1821-1829. doi: 10.1038/s41436-020-0905-3. Epub 2020 Jul 16.

DOI:10.1038/s41436-020-0905-3
PMID:32669677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8477450/
Abstract

PURPOSE

Secondary findings are typically offered in an all or none fashion when sequencing is used for clinical purposes. This study aims to describe the process of offering categorical and granular choices for results in a large research consortium.

METHODS

Within the third phase of the electronic MEdical Records and GEnomics (eMERGE) Network, several sites implemented studies that allowed participants to choose the type of results they wanted to receive from a multigene sequencing panel. Sites were surveyed to capture the details of the implementation protocols and results of these choices.

RESULTS

Across the ten eMERGE sites, 4664 participants including adolescents and adults were offered some type of choice. Categories of choices offered and methods for selecting categories varied. Most participants (94.5%) chose to learn all genetic results, while 5.5% chose subsets of results. Several sites allowed participants to change their choices at various time points, and 0.5% of participants made changes.

CONCLUSION

Offering choices that include learning some results is important and should be a dynamic process to allow for changes in scientific knowledge, participant age group, and individual preference.

摘要

目的

当测序用于临床目的时,通常以全有或全无的方式提供次要发现。本研究旨在描述在大型研究联盟中为结果提供分类和粒度选择的过程。

方法

在电子病历和基因组学 (eMERGE) 网络的第三阶段,几个站点实施了研究,允许参与者从多基因测序面板中选择他们想要接收的结果类型。对站点进行了调查,以获取实施协议的详细信息和这些选择的结果。

结果

在十个 eMERGE 站点中,包括青少年和成年人在内的 4664 名参与者提供了某种类型的选择。提供的选择类别和选择类别的方法有所不同。大多数参与者(94.5%)选择了解所有遗传结果,而 5.5%选择了部分结果。一些站点允许参与者在不同的时间点更改他们的选择,有 0.5%的参与者进行了更改。

结论

提供包括了解部分结果的选择很重要,并且应该是一个动态的过程,以允许科学知识、参与者年龄组和个人偏好的变化。

相似文献

1
Participant choices for return of genomic results in the eMERGE Network.eMERGE 网络中基因组结果回报的参与者选择。
Genet Med. 2020 Nov;22(11):1821-1829. doi: 10.1038/s41436-020-0905-3. Epub 2020 Jul 16.
2
The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network.核算:向 eMERGE3 网络的 1444 名参与者返还基因组学结果。
Genet Med. 2022 May;24(5):1130-1138. doi: 10.1016/j.gim.2022.01.015. Epub 2022 Feb 23.
3
Return of genomic results to research participants: the floor, the ceiling, and the choices in between.研究参与者的基因组结果返还:底线、上限和中间选择。
Am J Hum Genet. 2014 Jun 5;94(6):818-26. doi: 10.1016/j.ajhg.2014.04.009. Epub 2014 May 8.
4
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies.eMERGE 网络:一个由生物库组成的联盟,与电子病历数据相关联,用于进行基因组研究。
BMC Med Genomics. 2011 Jan 26;4:13. doi: 10.1186/1755-8794-4-13.
5
Giving adolescents a voice: the types of genetic information adolescents choose to learn and why.赋予青少年话语权:青少年选择学习的遗传信息类型及原因。
Genet Med. 2019 Apr;21(4):965-971. doi: 10.1038/s41436-018-0320-1. Epub 2018 Oct 29.
6
Eliciting preferences on secondary findings: the Preferences Instrument for Genomic Secondary Results.引出对次要发现的偏好:基因组次要结果偏好工具
Genet Med. 2017 Mar;19(3):337-344. doi: 10.1038/gim.2016.110. Epub 2016 Aug 25.
7
Participant Satisfaction With a Preference-Setting Tool for the Return of Individual Research Results in Pediatric Genomic Research.儿科基因组研究中个体研究结果反馈偏好设定工具的参与者满意度
J Empir Res Hum Res Ethics. 2015 Oct;10(4):414-26. doi: 10.1177/1556264615599620.
8
Studying the impact of translational genomic research: Lessons from eMERGE.研究转化基因组研究的影响:eMERGE 的经验教训。
Am J Hum Genet. 2023 Jul 6;110(7):1021-1033. doi: 10.1016/j.ajhg.2023.05.011. Epub 2023 Jun 20.
9
Research Participants' Preferences for Hypothetical Secondary Results from Genomic Research.研究参与者对基因组研究假设性次要结果的偏好。
J Genet Couns. 2017 Aug;26(4):841-851. doi: 10.1007/s10897-016-0059-2. Epub 2016 Dec 29.
10
Adolescents' and Parents' Genomic Testing Decisions: Associations With Age, Race, and Sex.青少年和家长的基因检测决策:与年龄、种族和性别有关。
J Adolesc Health. 2020 Mar;66(3):288-295. doi: 10.1016/j.jadohealth.2019.08.028. Epub 2019 Nov 1.

引用本文的文献

1
Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease.研究参与者对了解阿尔茨海默病生物标志物检测结果的兴趣。
JAMA Netw Open. 2025 May 1;8(5):e252919. doi: 10.1001/jamanetworkopen.2025.2919.
2
Global Perspectives on Returning Genetic Research Results in Parkinson Disease.帕金森病基因研究结果反馈的全球视角
Neurol Genet. 2024 Dec 5;10(6):e200213. doi: 10.1212/NXG.0000000000200213. eCollection 2024 Dec.
3
Promise and Peril of a Genotype-First Approach to Mendelian Cardiovascular Disease.基因型优先策略在孟德尔心血管疾病诊治中的机遇与挑战。
J Am Heart Assoc. 2024 Nov 5;13(21):e033557. doi: 10.1161/JAHA.123.033557. Epub 2024 Oct 18.
4
Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education.纳入基于网络的结果披露前教育的遗传研究结果和患者报告结局的接受情况与结果回报。
J Clin Oncol. 2023 Nov 1;41(31):4905-4915. doi: 10.1200/JCO.22.00516. Epub 2023 Aug 23.
5
Investigation of interest in and timing preference for cancer predisposition testing and expanded carrier screening among women of reproductive age.对育龄女性进行癌症易感性检测及扩大携带者筛查的兴趣和时间偏好调查。
PEC Innov. 2023 Jan 24;2:100128. doi: 10.1016/j.pecinn.2023.100128. eCollection 2023 Dec.
6
Return of Results in Genomic Research Using Large-Scale or Whole Genome Sequencing: Toward a New Normal.使用大规模或全基因组测序进行基因组研究的结果回报:迈向新常态。
Annu Rev Genomics Hum Genet. 2023 Aug 25;24:393-414. doi: 10.1146/annurev-genom-101122-103209. Epub 2023 Mar 13.
7
When is the best time to screen and evaluate for treatable genetic disorders?: A lifespan perspective.何时是筛查和评估可治疗遗传疾病的最佳时机?:从寿命角度看。
Am J Med Genet C Semin Med Genet. 2023 Mar;193(1):44-55. doi: 10.1002/ajmg.c.32036. Epub 2023 Mar 6.
8
Harnessing the potential of machine learning and artificial intelligence for dementia research.利用机器学习和人工智能在痴呆症研究中的潜力。
Brain Inform. 2023 Feb 24;10(1):6. doi: 10.1186/s40708-022-00183-3.
9
An spanish study of secondary findings in families affected with mendelian disorders: choices, prevalence and family history.一项针对伴有孟德尔疾病的家族中的二级发现的西班牙研究:选择、患病率和家族史。
Eur J Hum Genet. 2023 Feb;31(2):223-230. doi: 10.1038/s41431-022-01240-5. Epub 2022 Nov 29.
10
Outcomes of Returning Medically Actionable Genomic Results in Pediatric Research.儿科研究中返回具有医学可操作性基因组结果的结局。
J Pers Med. 2022 Nov 16;12(11):1910. doi: 10.3390/jpm12111910.

本文引用的文献

1
Returning Results in the Genomic Era: Initial Experiences of the eMERGE Network.基因组时代的结果反馈:eMERGE网络的初步经验
J Pers Med. 2020 Apr 27;10(2):30. doi: 10.3390/jpm10020030.
2
Adolescents' and Parents' Genomic Testing Decisions: Associations With Age, Race, and Sex.青少年和家长的基因检测决策:与年龄、种族和性别有关。
J Adolesc Health. 2020 Mar;66(3):288-295. doi: 10.1016/j.jadohealth.2019.08.028. Epub 2019 Nov 1.
3
Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.协调 eMERGE III 网络的临床测序和解读。
Am J Hum Genet. 2019 Sep 5;105(3):588-605. doi: 10.1016/j.ajhg.2019.07.018. Epub 2019 Aug 22.
4
Return of individual genomic research results: are laws and policies keeping step?个体基因组研究结果的返还:法律法规是否跟上步伐?
Eur J Hum Genet. 2019 Apr;27(4):535-546. doi: 10.1038/s41431-018-0311-3. Epub 2019 Jan 8.
5
Responsibility, identity, and genomic sequencing: A comparison of published recommendations and patient perspectives on accepting or declining incidental findings.责任、身份认同与基因组测序:已发表建议与患者对接受或拒绝偶然发现的观点之比较
Mol Genet Genomic Med. 2018 Nov;6(6):1079-1096. doi: 10.1002/mgg3.485. Epub 2018 Oct 28.
6
Giving adolescents a voice: the types of genetic information adolescents choose to learn and why.赋予青少年话语权:青少年选择学习的遗传信息类型及原因。
Genet Med. 2019 Apr;21(4):965-971. doi: 10.1038/s41436-018-0320-1. Epub 2018 Oct 29.
7
Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience.转化基因组学研究中携带者检测及结果披露的方法:临床测序探索性研究联盟的经验
Mol Genet Genomic Med. 2018 Nov;6(6):898-909. doi: 10.1002/mgg3.453. Epub 2018 Aug 21.
8
The Genomics ADvISER: development and usability testing of a decision aid for the selection of incidental sequencing results.基因组学顾问:选择偶然测序结果的决策辅助工具的开发和可用性测试。
Eur J Hum Genet. 2018 Jul;26(7):984-995. doi: 10.1038/s41431-018-0144-0. Epub 2018 Apr 27.
9
Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG).儿科临床外显子组/基因组测序与参与过程:鼓励与大龄儿童及青少年进行积极沟通:需考虑的要点——美国医学遗传学与基因组学学会(ACMG)声明
Genet Med. 2018 Jul;20(7):692-694. doi: 10.1038/gim.2018.36. Epub 2018 Mar 22.
10
Impact of Receiving Secondary Results from Genomic Research: A 12-Month Longitudinal Study.接受基因组研究二次结果的影响:一项为期12个月的纵向研究。
J Genet Couns. 2018 Jun;27(3):709-722. doi: 10.1007/s10897-017-0172-x. Epub 2017 Nov 22.